This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
METHOXACET-C1/8 (2015-01-27)
- Starting date:
- January 27, 2015
- Posting date:
- February 2, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-43603
Recalled Products
METHOXACET-C1/8
Reason
An OOS Codeine Phosphate assay result was reported at 24 months stability testing.
Depth of distribution
Wholesalers
Affected products
METHOXACET-C1/8
DIN, NPN, DIN-HIM
DIN 02236872
Dosage form
Caplets
Strength
Methocarbamol 400 mg
Acetaminophen 325 mg
Codeine phosphate 8 mg
Lot or serial number
664758A
664758B
669629
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA